NOVONIX Ltd current report, Q3 FY2026

Business Context and Reporting Period

Company: NOVONIX Ltd (Foreign Private Issuer)
Filing Type: Form 6-K
Reporting Period: Month of July 2026
Date Filed: July 03, 2026
Principal Executive Office: Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K serves as a cover sheet for an exhibit and does not contain financial statements or performance data.

Material Changes

The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or operational updates are included in the provided text.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to administrative details and an exhibit index.

Key Facts for Investor Verification

  • The filing includes Exhibit 99.1, described as "Appendix 2A (Application for quotation of securities)" dated July 2, 2026.
  • The registrant files annual reports under Form 20-F.
  • The report was signed by Mike O'Kronley, Chief Executive Officer.
  • Investors should review the attached Exhibit 99.1 for details regarding the application for quotation of securities, as the cover sheet contains no substantive business data.